Showing 149,621 - 149,640 results of 228,304 for search '(( 5 ((point decrease) OR (mean decrease)) ) OR ( 10 ((teer decrease) OR (a decrease)) ))', query time: 2.03s Refine Results
  1. 149621

    Perspectives on research DTTC (Thomas et al., 2025) by Donna Thomas (12427672)

    Published 2025
    “…<i>American Journal of Speech-Language Patholog</i><i>y, </i><i>34</i>(4S), 2509–2518. <a href="https://doi.org/10.1044/2024_AJSLP-24-00228" rel="noreferrer" target="_blank">https://doi.org/10.1044/2024_AJSLP-24-00228</a></p><p dir="ltr"><b>Publisher Note:</b> This article is part of the Special Issue: Select Papers From the 2024 Conference on Motor Speech—Clinical Science and Implications.…”
  2. 149622

    Spike inference applied to Pavlovian conditioning <i>in vivo</i> imaging data recapitulates transient cue responses, pauses following reward omission, and previously reported relat... by Weston Fleming (10924744)

    Published 2021
    “…Neurons that exhibited a significant decrease in firing following reward omission (22/65 neurons; 33.9% of population) are darker green. …”
  3. 149623

    Validation of epigenetic mechanisms regulating gene expression in canine B-cell lymphoma: An <i>in vitro</i> and <i>in vivo</i> approach by Silvia Da Ros (607525)

    Published 2018
    “…To validate data previously obtained by array analysis, the CLBL-1 cell line was used and the <i>HOXD10</i>, <i>FGFR2</i>, <i>ITIH5</i> and <i>RASAL3</i> genes were selected. …”
  4. 149624
  5. 149625
  6. 149626
  7. 149627
  8. 149628
  9. 149629
  10. 149630
  11. 149631

    Image8_Mitomycin-Treated Endothelial and Smooth Muscle Cells Suitable for Safe Tissue Engineering Approaches.TIF by Irina Zakharova (766005)

    Published 2022
    “…Endothelial and smooth muscle cells were treated with mitomycin C at a therapeutic concentration of 10 μg/ml for 2 h with subsequent analysis of cell proliferation and function. …”
  12. 149632

    Table1_Mitomycin-Treated Endothelial and Smooth Muscle Cells Suitable for Safe Tissue Engineering Approaches.XLSX by Irina Zakharova (766005)

    Published 2022
    “…Endothelial and smooth muscle cells were treated with mitomycin C at a therapeutic concentration of 10 μg/ml for 2 h with subsequent analysis of cell proliferation and function. …”
  13. 149633

    Image4_Mitomycin-Treated Endothelial and Smooth Muscle Cells Suitable for Safe Tissue Engineering Approaches.TIF by Irina Zakharova (766005)

    Published 2022
    “…Endothelial and smooth muscle cells were treated with mitomycin C at a therapeutic concentration of 10 μg/ml for 2 h with subsequent analysis of cell proliferation and function. …”
  14. 149634

    Image3_Mitomycin-Treated Endothelial and Smooth Muscle Cells Suitable for Safe Tissue Engineering Approaches.TIF by Irina Zakharova (766005)

    Published 2022
    “…Endothelial and smooth muscle cells were treated with mitomycin C at a therapeutic concentration of 10 μg/ml for 2 h with subsequent analysis of cell proliferation and function. …”
  15. 149635

    Image5_Mitomycin-Treated Endothelial and Smooth Muscle Cells Suitable for Safe Tissue Engineering Approaches.TIF by Irina Zakharova (766005)

    Published 2022
    “…Endothelial and smooth muscle cells were treated with mitomycin C at a therapeutic concentration of 10 μg/ml for 2 h with subsequent analysis of cell proliferation and function. …”
  16. 149636

    Video1_Mitomycin-Treated Endothelial and Smooth Muscle Cells Suitable for Safe Tissue Engineering Approaches.mov by Irina Zakharova (766005)

    Published 2022
    “…Endothelial and smooth muscle cells were treated with mitomycin C at a therapeutic concentration of 10 μg/ml for 2 h with subsequent analysis of cell proliferation and function. …”
  17. 149637

    Image1_Mitomycin-Treated Endothelial and Smooth Muscle Cells Suitable for Safe Tissue Engineering Approaches.TIF by Irina Zakharova (766005)

    Published 2022
    “…Endothelial and smooth muscle cells were treated with mitomycin C at a therapeutic concentration of 10 μg/ml for 2 h with subsequent analysis of cell proliferation and function. …”
  18. 149638

    DataSheet1_Mitomycin-Treated Endothelial and Smooth Muscle Cells Suitable for Safe Tissue Engineering Approaches.docx by Irina Zakharova (766005)

    Published 2022
    “…Endothelial and smooth muscle cells were treated with mitomycin C at a therapeutic concentration of 10 μg/ml for 2 h with subsequent analysis of cell proliferation and function. …”
  19. 149639

    Image2_Mitomycin-Treated Endothelial and Smooth Muscle Cells Suitable for Safe Tissue Engineering Approaches.TIF by Irina Zakharova (766005)

    Published 2022
    “…Endothelial and smooth muscle cells were treated with mitomycin C at a therapeutic concentration of 10 μg/ml for 2 h with subsequent analysis of cell proliferation and function. …”
  20. 149640

    Image7_Mitomycin-Treated Endothelial and Smooth Muscle Cells Suitable for Safe Tissue Engineering Approaches.TIF by Irina Zakharova (766005)

    Published 2022
    “…Endothelial and smooth muscle cells were treated with mitomycin C at a therapeutic concentration of 10 μg/ml for 2 h with subsequent analysis of cell proliferation and function. …”